35 results
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
Opioid Use Disorder Medications ... discontinuation of the medication ... the sublingual tablet ... #UseDisorder #Medications ... Pharmacokinetics #Comparison #Table
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... #Classification ... #Classes #Cardiology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... GLP-1 receptor agonists ... #table #comparison ... endocrinology #dm2
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... of action, side effect ... #pharmacology #dm2 ... #diabetes #medications
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... Ozempic), or daily tablet ... not definitively cause ... GLP1 #Receptor #Agonists ... Pharmacology #Summary #DM2
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... mistaken these medications ... to the incretin effect ... Common side effects ... Dosing #Diabetes #DM2
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
and Management Algorithm ... relative with DM2 ... • Secondary Causes ... Rubella) • Medications ... #DM2 #DMII #Classification
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
GLP-I receptor agonist ... failure Common Side Effects ... not definitively cause ... /effect) • Saxagliptin ... Pharmacology #Summary #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... GLP-1 receptor agonist ... Diabetes #Mellitus #DM2 ... pharmacology #comparison #table
Shock - Differential Diagnosis by Classification
Reflex Syncope 
 - Vasovagal syncope
   • Prolonged standing
Differential Diagnosis by Classification ... depletion - Medication ... side effect (e.g ... side effect (e.g ... #Table #Causes